These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 20433125

  • 1. Risperidone vs. placebo for schizophrenia.
    Kripke C.
    Am Fam Physician; 2010 May 01; 81(9):1096. PubMed ID: 20433125
    [No Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1397-406. PubMed ID: 19906343
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S.
    Expert Rev Neurother; 2009 Jan 01; 9(1):9-31. PubMed ID: 19102665
    [Abstract] [Full Text] [Related]

  • 5. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
    Kane JM.
    J Clin Psychiatry; 2003 Jan 01; 64 Suppl 16():34-40. PubMed ID: 14680417
    [Abstract] [Full Text] [Related]

  • 6. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep 01; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Int Clin Psychopharmacol; 2008 Nov 01; 23(6):325-31. PubMed ID: 18854720
    [Abstract] [Full Text] [Related]

  • 9. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA, Bettinger TL, Argo TR.
    Clin Ther; 2008 Feb 01; 30(2):231-48. PubMed ID: 18343262
    [Abstract] [Full Text] [Related]

  • 10. Long-acting injectable risperidone.
    Ehret MJ, Fuller MA.
    Ann Pharmacother; 2004 Dec 01; 38(12):2122-7. PubMed ID: 15522979
    [Abstract] [Full Text] [Related]

  • 11. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR, Conley R, Ereshefsky L, Kane JM, Turner MS.
    J Clin Psychiatry; 2003 Dec 01; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics.
    Ereshefsky L, Mascarenas CA.
    J Clin Psychiatry; 2003 Dec 01; 64 Suppl 16():18-23. PubMed ID: 14680415
    [Abstract] [Full Text] [Related]

  • 13. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED, Stimmel GL.
    Clin Ther; 2004 Dec 01; 26(12):1994-2002. PubMed ID: 15823763
    [Abstract] [Full Text] [Related]

  • 14. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S.
    J Psychopharmacol; 2005 Sep 01; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract] [Full Text] [Related]

  • 15. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety.
    Hawley C, Turner M, Latif MA, Curtis V, Saleem PT, Wilton K.
    Hum Psychopharmacol; 2010 Jan 01; 25(1):37-46. PubMed ID: 20041474
    [Abstract] [Full Text] [Related]

  • 16. Use of long-acting risperidone.
    Parker G.
    Psychiatr Serv; 2005 Jan 01; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
    [No Abstract] [Full Text] [Related]

  • 17. Is depot medication safe in the setting of myopathy?
    Price JR, Bastiampillai T, Dhillon RS.
    Aust N Z J Psychiatry; 2009 Aug 01; 43(8):781-3. PubMed ID: 19629801
    [No Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets.
    Chue P, Eerdekens M, Augustyns I, Lachaux B, Molcan P, Eriksson L, Pretorius H, David AS.
    Eur Neuropsychopharmacol; 2005 Jan 01; 15(1):111-7. PubMed ID: 15572280
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 20. Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.
    Citrome L.
    Int J Clin Pract; 2010 Jan 01; 64(2):216-39. PubMed ID: 19886879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.